Dallah Healthcare Co. reported a net profit of SAR 471.2 million for 2024, an increase of 31% from SAR 360.1 million a year earlier.
Item | 2023 | 2024 | Change |
---|---|---|---|
Revenues | 2,942.90 | 3,205.73 | 8.9 % |
Gross Income | 1,078.67 | 1,206.84 | 11.9 % |
Operating Income | 506.31 | 567.12 | 12.0 % |
Net Income | 360.12 | 471.20 | 30.8 % |
Average Shares | 97.68 | 97.68 | - |
Earnings Per Share before unusual items (Riyals) | 3.69 | 4.82 | 30.8 % |
EPS (Riyals) | 3.69 | 4.82 | 30.8 % |
The annual net profit was propelled by an 8.9% year-on-year (YoY) rise in revenue to SAR 3.20 billion, thanks to increased operating capacity, performance efficiency and the continued growth in the number of patients.
The company also cited an 11.9% YoY increase in gross profit to SAR 1.20 billion. The performance of associates improved, as they recorded profits of SAR 43 million in 2024, against a loss of SAR 2 million last year. Gross profit margins expanded to 37.6% in 2024, from SAR 36.7% a year earlier.
The full-year earnings before interest, taxes, depreciation and amortization (EBITDA) increased by 19.1% YoY to SAR 751 million.
Item | Q4 2023 | Q4 2024 | Change |
---|---|---|---|
Revenues | 806.01 | 808.76 | 0.3 % |
Gross Income | 295.94 | 292.76 | (1.1 %) |
Operating Income | 134.34 | 115.40 | (14.1 %) |
Net Income | 113.65 | 113.90 | 0.2 % |
Average Shares | 97.68 | 97.68 | - |
Earnings Per Share before unusual items (Riyals) | 1.16 | 1.17 | 0.2 % |
EPS (Riyals) | 1.16 | 1.17 | 0.2 % |
Item | Q3 2024 | Q4 2024 | Change |
---|---|---|---|
Revenues | 847.73 | 808.76 | (4.6 %) |
Gross Income | 322.99 | 292.76 | (9.4 %) |
Operating Income | 161.42 | 115.40 | (28.5 %) |
Net Income | 126.15 | 113.90 | (9.7 %) |
Average Shares | 97.68 | 97.68 | - |
Earnings Per Share before unusual items (Riyals) | 1.29 | 1.17 | (9.7 %) |
EPS (Riyals) | 1.29 | 1.17 | (9.7 %) |
The fourth-quarter net earnings were almost flat at SAR 113.9 million, compared to SAR 113.6 million in Q4 2023.
However, net earnings decreased by 9.7% quarter-on-quarter (QoQ) from 126.1 million in Q3 2024.
Total shareholders’ equity, after minority interest, increased to SAR 3.46 billion as of Dec. 31, 2024, from SAR 3.20 billion a year earlier.
Attached Documents
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}